![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1279915
¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Cryoablation Devices Market Size study & Forecast, by Product by Application, by End Use and Regional Analysis, 2023-2030 |
¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº 2022³â ¾à 3¾ï 7,403¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 13.70% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
³Ãµ¿ ÀýÁ¦ ±â±â´Â ±ØÀú¿Â¿¡¼ ¿øÄ¡ ¾Ê´Â Á¶Á÷À» ÆÄ±«ÇÏ¿© ´Ù¾çÇÑ Áõ»óÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ Àåºñ´Â ¾×ü Áú¼Ò ¶Ç´Â ¾Æ¸£°ï °¡½ºÀÇ Á¦¾î µÈ È帧À» Ç¥Àû Á¶Á÷¿¡ °ø±ÞÇÏ¿© Á¶Á÷À» µ¿°á½ÃŰ°í ±Ã±ØÀûÀ¸·Î Á¶Á÷À» Á×ÀÌ´Â ¹æ½ÄÀ¸·Î ÀÛµ¿ÇÕ´Ï´Ù. ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº ¾Ï À¯º´·ü Áõ°¡, ½É¹æ¼¼µ¿ À¯º´·ü Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
±¹Á¦¾Ï¿¬±¸¼Ò(IARC)ÀÇ ÃßÁ¤¿¡ µû¸£¸é ¼¼°è ¾Ï ¹ß»ýÀÌ 2021³â 190¸¸ ¸í¿¡¼ 2040³â±îÁö 2,750¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¾Ï À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ CDC´Â 2030³â±îÁö 1,200¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ½É¹æ¼¼µ¿À» ¾Î°Ô µÉ °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½É¹æ¼¼µ¿Àº ¹Ì±¹¿¡¼ ¸Å³â 45¸¸ °Ç¿¡ °¡±î¿î º´¿ø ÀÔ¿øÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ Áß ½É¹æ¼¼µ¿ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀåÀº ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ ±â¼ú ¹ßÀü°ú ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁöÃâ Áõ°¡´Â ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ³Ãµ¿ ÀýÁ¦ ±â±âÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ³Ãµ¿ ÀýÁ¦ ±â±â ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÇ´Â ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ¿ìÀ§, ¾Ï À¯º´·ü Áõ°¡, Ȱ¹ßÇÑ R&D Ȱµ¿À¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ ¹× ¾Ï À¯º´·ü Áõ°¡, Àåºñ °³¹ßÀ» À§ÇÑ °øµ¿ ¿¬±¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¿ªÀû È®Àå, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¼ö³â°£ÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.
Global Cryoablation Devices Market is valued at approximately USD 374.03 million in 2022 and is anticipated to grow with a healthy growth rate of more than 13.70% over the forecast period 2023-2030. Cryoablation devices are medical instruments used to treat a variety of conditions by using extremely cold temperatures to destroy unwanted tissue. The devices work by delivering a controlled stream of liquid nitrogen or argon gas to the target tissue, which causes the tissue to freeze and ultimately die. The Cryoablation Devices Market is expanding because of factors such as the increasing prevalence of cancer, the rising prevalence of atrial fibrillation and the growing demand for minimally invasive surgeries.
The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, by 2030, the CDC estimated that 12 million Americans would have atrial fibrillation.. In addition, atrial fibrillation was the primary diagnosis in almost 450,000 hospital admissions in the United States each year. During the projection period, it is anticipated that the market for cryoablation devices would have increased demand due to the rising prevalence of atrial fibrillation. In Addition, the rising number of technological advancements in cryoablation devices and rising spending on research and development activities are creating a lucrative opportunity for the market. However, the high cost of Cryoablation Devices may hamper the market growth.
The key regions considered for the Global Cryoablation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to dominance of key market players, the rising prevalence of cancer and rising research and development activities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and cancer prevalence, an increase in the number of collaborations for device development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.